Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-26 @ 1:36 AM
Study NCT ID:
NCT05093933
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2021-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-18
First Submit QC Date:
None
Study First Post Date:
2021-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-04
Results First Submit QC Date:
None
Results First Post Date:
2025-12-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED